{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:03:48Z","timestamp":1790046228215,"version":"4.0.1"},"reference-count":38,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.3892\/mmr.2015.3542","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T12:42:44Z","timestamp":1427200964000},"page":"1485-1492","source":"Crossref","is-referenced-by-count":27,"title":["Overexpression of Tyro3 receptor tyrosine kinase leads to the acquisition of taxol resistance in ovarian cancer cells"],"prefix":"10.3892","volume":"12","author":[{"given":"CHUHEE","family":"LEE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,3,24]]},"reference":[{"key":"key20180108022505_b1-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"3 Suppl 6","key":"key20180108022505_b2-mmr-12-01-1485","first-page":"90","article-title":"M Paclitaxel, cisplatin, and cyclophosphamide in human ovarian cancer: molecular rationale and early clinical results","volume":"22","author":"Reed","year":"1995","journal-title":"Semin Oncol"},{"issue":"12","key":"key20180108022505_b3-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1093\/annonc\/mdt406","article-title":"Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data","volume":"24","author":"Raja","year":"2013","journal-title":"Ann Oncol"},{"key":"key20180108022505_b4-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1992.10.11.1748","article-title":"Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma","volume":"10","author":"Einzig","year":"1992","journal-title":"J Clin Oncol"},{"key":"key20180108022505_b5-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ygyno.2011.11.022","article-title":"Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study","volume":"124","author":"Tian","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20180108022505_b6-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl 10","key":"key20180108022505_b7-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1200\/JCO.2003.01.066","article-title":"Current status of taxane and platinum-based chemotherapy in ovarian cancer","volume":"21","author":"McGuire","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180108022505_b8-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminoncol.2006.03.011","article-title":"Systemic therapy for ovarian cancer: current status and new treatments","volume":"33","author":"Ozols","year":"2006","journal-title":"Semin Oncol"},{"key":"key20180108022505_b9-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1038\/sj.onc.1203957","article-title":"The protein tyrosine kinase family of the human genome","volume":"19","author":"Robinson","year":"2000","journal-title":"Oncogene"},{"key":"key20180108022505_b10-mmr-12-01-1485","first-page":"699","article-title":"Cloning of the cDNA for a novel receptor tyrosine kinase, Sky, predominantly expressed in brain","volume":"9","author":"Ohashi","year":"1994","journal-title":"Oncogene"},{"key":"key20180108022505_b11-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1128\/MCB.11.10.5016","article-title":"axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase","volume":"11","author":"O\u2019Bryan","year":"1991","journal-title":"Mol Cell Biol"},{"key":"key20180108022505_b12-mmr-12-01-1485","first-page":"2113","article-title":"A novel putative tyrosine kinase receptor with oncogenic potential","volume":"6","author":"Janssen","year":"1991","journal-title":"Oncogene"},{"key":"key20180108022505_b13-mmr-12-01-1485","first-page":"1909","article-title":"A putative receptor tyrosine kinase with unique structural topology","volume":"6","author":"Rescigno","year":"1991","journal-title":"Oncogene"},{"key":"key20180108022505_b14-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.emboj.7600912","article-title":"Structural basis for Gas6-Axl signalling","volume":"25","author":"Sasaki","year":"2006","journal-title":"EMBO J"},{"key":"key20180108022505_b15-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0092-8674(95)90520-0","article-title":"The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3\/Axl family of receptor tyrosine kinases","volume":"80","author":"Stitt","year":"1995","journal-title":"Cell"},{"key":"key20180108022505_b16-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1111\/j.1742-4658.2006.05529.x","article-title":"Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily","volume":"273","author":"Hafizi","year":"2006","journal-title":"FEBS J"},{"key":"key20180108022505_b17-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1677\/erc.0.0080161","article-title":"Receptor tyrosine kinase signalling as a target for cancer intervention strategies","volume":"8","author":"Zwick","year":"2001","journal-title":"Endocr Relat Cancer"},{"key":"key20180108022505_b18-mmr-12-01-1485","first-page":"781","article-title":"Differential expression of the ufo\/axl oncogene in human leukemia-lymphoma cell lines","volume":"10","author":"Challier","year":"1996","journal-title":"Leukemia"},{"key":"key20180108022505_b19-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1158\/1078-0432.CCR-05-2208","article-title":"Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia","volume":"12","author":"Graham","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180108022505_b20-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.V98.3.771","article-title":"Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays","volume":"98","author":"De Vos","year":"2001","journal-title":"Blood"},{"key":"key20180108022505_b21-mmr-12-01-1485","first-page":"361","article-title":"Expression profile of tyrosine kinases in breast cancer","volume":"8","author":"Meric","year":"2002","journal-title":"Clin Cancer Res"},{"key":"key20180108022505_b22-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature06487","article-title":"Endogenous human microRNAs that suppress breast cancer metastasis","volume":"451","author":"Tavazoie","year":"2008","journal-title":"Nature"},{"key":"key20180108022505_b23-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ijc.2910600611","article-title":"Receptor tyrosine kinases expressed in metastatic colon cancer","volume":"60","author":"Craven","year":"1995","journal-title":"Int J Cancer"},{"key":"key20180108022505_b24-mmr-12-01-1485","first-page":"1071","article-title":"Clinical significance of AXL kinase family in gastric cancer","volume":"22","author":"Wu","year":"2002","journal-title":"Anticancer Res"},{"key":"key20180108022505_b25-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/geno.1998.5338","article-title":"Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma","volume":"50","author":"Tsou","year":"1998","journal-title":"Genomics"},{"key":"key20180108022505_b26-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.jid.5700543","article-title":"A Web-based data warehouse on gene expression in human malignant melanoma","volume":"127","author":"Gy\u00f6rffy","year":"2007","journal-title":"J Invest Dermatol"},{"key":"key20180108022505_b27-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1158\/0008-5472.CAN-04-2684","article-title":"Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer","volume":"65","author":"Macleod","year":"2005","journal-title":"Cancer Res"},{"key":"key20180108022505_b28-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jcp.20265","article-title":"Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor","volume":"204","author":"Sainaghi","year":"2005","journal-title":"J Cell Physiol"},{"key":"key20180108022505_b29-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/10445490360708946","article-title":"Expression of the proto-oncogene Axl in renal cell carcinoma","volume":"22","author":"Chung","year":"2003","journal-title":"DNA Cell Biol"},{"key":"key20180108022505_b30-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1158\/0008-5472.CAN-03-0245","article-title":"Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival","volume":"64","author":"van Ginkel","year":"2004","journal-title":"Cancer Res"},{"key":"key20180108022505_b31-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/jps.20874","article-title":"Oxidative stress and apoptosis: impact on cancer therapy","volume":"96","author":"Ozben","year":"2007","journal-title":"J Pharm Sci"},{"key":"key20180108022505_b32-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jcb.21655","article-title":"Reactive oxygen species: current knowledge and applications in cancer research and therapeutic","volume":"104","author":"Lau","year":"2008","journal-title":"J Cell Biochem"},{"key":"key20180108022505_b33-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-60327-492-0_20","article-title":"Epidemiology of ovarian cancer","volume":"472","author":"Permuth-Wey","year":"2009","journal-title":"Methods Mol Biol"},{"key":"key20180108022505_b34-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2772","article-title":"Senescence in tumours: evidence from mice and humans","volume":"10","author":"Collado","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"key20180108022505_b35-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1182\/blood-2010-10-313692","article-title":"Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells","volume":"118","author":"Gioia","year":"2011","journal-title":"Blood"},{"key":"key20180108022505_b36-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"874","DOI":"10.18632\/oncotarget.360","article-title":"Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells","volume":"2","author":"Dufies","year":"2011","journal-title":"Oncotarget"},{"key":"key20180108022505_b37-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"37813","DOI":"10.1074\/jbc.M110.200675","article-title":"Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species","volume":"286","author":"Achuthan","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180108022505_b38-mmr-12-01-1485","doi-asserted-by":"crossref","first-page":"15521","DOI":"10.1523\/JNEUROSCI.4437-10.2010","article-title":"Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormone-binding globulin-like region","volume":"30","author":"Zhong","year":"2010","journal-title":"J Neurosci"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3542\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T04:28:05Z","timestamp":1515385685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,3,24]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.3892\/mmr.2015.3542"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3542","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,24]]}}}